I wrote briefly a few months ago about Altos Labs. It’s a new kind of biotech institute that is focused on cellular reprogramming. My original piece was sparked in part by an article around the same time by Antonio Regalado over at MIT Tech Review. He provided some tantalizing details on Altos. Also, I had heard some …
Perspectives on Altos Labs and its $3B cellular rejuvenation push Read More »
The post Perspectives on Altos Labs and its $3B cellular rejuvenation push appeared first on The Niche.